ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2014
Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.